| Application number | Title of the application | Filing Date | Status |
|---|
| 08/402970 | HUMAN PARATHYROID HORMONE MUTEINS AND PRODUCTION THEREOF | Mar 9, 1995 | Abandoned |
Array
(
[id] => 3627422
[patent_doc_number] => 05621078
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-04-15
[patent_title] => 'Modified pseudomonas exotoxin PE.sub.40'
[patent_app_type] => 1
[patent_app_number] => 8/391259
[patent_app_country] => US
[patent_app_date] => 1995-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7685
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/621/05621078.pdf
[firstpage_image] =>[orig_patent_app_number] => 391259
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/391259 | Modified pseudomonas exotoxin PE.sub.40 | Feb 20, 1995 | Issued |
| 08/384710 | NOVEL MLK RECEPTOR TYROSINE KINASES | Jan 31, 1995 | Abandoned |
| 08/380227 | METHOD FOR PREPARING WATER SOLUBLE PEPTIDES | Jan 29, 1995 | Abandoned |
Array
(
[id] => 3895566
[patent_doc_number] => 05750502
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-05-12
[patent_title] => 'Cloning, expression and uses of a secreted protein, F-spondin'
[patent_app_type] => 1
[patent_app_number] => 8/313288
[patent_app_country] => US
[patent_app_date] => 1995-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 40
[patent_no_of_words] => 15798
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/750/05750502.pdf
[firstpage_image] =>[orig_patent_app_number] => 313288
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/313288 | Cloning, expression and uses of a secreted protein, F-spondin | Jan 4, 1995 | Issued |
| 08/349915 | SINGLE CHAIN T-CELL RECEPTOR | Dec 5, 1994 | Abandoned |
| 08/352163 | MEL-CAM LIGAND AND ITS USE | Nov 30, 1994 | Abandoned |
| 08/347893 | SOLUBLE SINGLE CHAIN T CELL RECEPTORS | Nov 30, 1994 | Abandoned |
Array
(
[id] => 3705982
[patent_doc_number] => 05654267
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-08-05
[patent_title] => 'Cooperative combinations of ligands contained within a matrix'
[patent_app_type] => 1
[patent_app_number] => 8/347942
[patent_app_country] => US
[patent_app_date] => 1994-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 10
[patent_no_of_words] => 11016
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/654/05654267.pdf
[firstpage_image] =>[orig_patent_app_number] => 347942
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/347942 | Cooperative combinations of ligands contained within a matrix | Nov 29, 1994 | Issued |
| 08/345151 | PEPTIDES | Nov 27, 1994 | Abandoned |
Array
(
[id] => 3780997
[patent_doc_number] => 05821084
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-10-13
[patent_title] => 'Osteoblast-testicular protein tyrosine phosphatase'
[patent_app_type] => 1
[patent_app_number] => 8/342930
[patent_app_country] => US
[patent_app_date] => 1994-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 13862
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 22
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/821/05821084.pdf
[firstpage_image] =>[orig_patent_app_number] => 342930
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/342930 | Osteoblast-testicular protein tyrosine phosphatase | Nov 20, 1994 | Issued |
Array
(
[id] => 3591216
[patent_doc_number] => 05585463
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-12-17
[patent_title] => '.beta..sub.3 integrin subunit specific polypeptides, cDNAs which encode these polypeptides and method of producing these polypeptides'
[patent_app_type] => 1
[patent_app_number] => 8/338009
[patent_app_country] => US
[patent_app_date] => 1994-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3763
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/585/05585463.pdf
[firstpage_image] =>[orig_patent_app_number] => 338009
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/338009 | .beta..sub.3 integrin subunit specific polypeptides, cDNAs which encode these polypeptides and method of producing these polypeptides | Nov 9, 1994 | Issued |
Array
(
[id] => 3666405
[patent_doc_number] => 05599792
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-02-04
[patent_title] => 'Bone-stimulating, non-vasoactive parathyroid hormone variants'
[patent_app_type] => 1
[patent_app_number] => 8/332453
[patent_app_country] => US
[patent_app_date] => 1994-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 10
[patent_no_of_words] => 6364
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/599/05599792.pdf
[firstpage_image] =>[orig_patent_app_number] => 332453
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/332453 | Bone-stimulating, non-vasoactive parathyroid hormone variants | Oct 30, 1994 | Issued |
Array
(
[id] => 3685905
[patent_doc_number] => 05643749
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-07-01
[patent_title] => 'Soluble interferon .alpha.-receptor, its preparation and use'
[patent_app_type] => 1
[patent_app_number] => 8/328256
[patent_app_country] => US
[patent_app_date] => 1994-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 11
[patent_no_of_words] => 9583
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/643/05643749.pdf
[firstpage_image] =>[orig_patent_app_number] => 328256
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/328256 | Soluble interferon .alpha.-receptor, its preparation and use | Oct 23, 1994 | Issued |
| 08/327118 | METHODS OF USE FOR INTEGRIN B1C CELL GROWTH INHIBITOR | Oct 20, 1994 | Abandoned |
Array
(
[id] => 3660871
[patent_doc_number] => 05648332
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-07-15
[patent_title] => 'Method of treating diabetes mellitus using variable .alpha. domain of T-cell receptor'
[patent_app_type] => 1
[patent_app_number] => 8/318881
[patent_app_country] => US
[patent_app_date] => 1994-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 4128
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/648/05648332.pdf
[firstpage_image] =>[orig_patent_app_number] => 318881
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/318881 | Method of treating diabetes mellitus using variable .alpha. domain of T-cell receptor | Oct 19, 1994 | Issued |
Array
(
[id] => 3692341
[patent_doc_number] => 05679546
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-10-21
[patent_title] => 'Chimeric proteins which block complement activation'
[patent_app_type] => 1
[patent_app_number] => 8/310416
[patent_app_country] => US
[patent_app_date] => 1994-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 15
[patent_no_of_words] => 13133
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/679/05679546.pdf
[firstpage_image] =>[orig_patent_app_number] => 310416
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/310416 | Chimeric proteins which block complement activation | Sep 21, 1994 | Issued |
| 08/307354 | INHIBITION OF ENDOTHELIN-1 TO REDUCE INFLAMMATORY PROCESSES | Sep 13, 1994 | Abandoned |
Array
(
[id] => 3792606
[patent_doc_number] => 05726152
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-03-10
[patent_title] => 'Vascular endothelial cell growth factor II'
[patent_app_type] => 1
[patent_app_number] => 8/299185
[patent_app_country] => US
[patent_app_date] => 1994-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 34
[patent_no_of_words] => 12854
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/726/05726152.pdf
[firstpage_image] =>[orig_patent_app_number] => 299185
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/299185 | Vascular endothelial cell growth factor II | Aug 30, 1994 | Issued |
Array
(
[id] => 3730745
[patent_doc_number] => 05652343
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-07-29
[patent_title] => 'Method for purification of L-selectin ligands'
[patent_app_type] => 1
[patent_app_number] => 8/294675
[patent_app_country] => US
[patent_app_date] => 1994-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 17
[patent_no_of_words] => 22691
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 126
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/652/05652343.pdf
[firstpage_image] =>[orig_patent_app_number] => 294675
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/294675 | Method for purification of L-selectin ligands | Aug 22, 1994 | Issued |